Journal
EXPERT REVIEW OF VACCINES
Volume 6, Issue 3, Pages 381-390Publisher
EXPERT REVIEWS
DOI: 10.1586/14760584.6.3.381
Keywords
antibody induction; cytotoxic T lyinphocyte; self-antigen; virus-fike particle
Categories
Funding
- NIAID NIH HHS [R01 AI065240] Funding Source: Medline
Ask authors/readers for more resources
Virus-like particles (VLPs) consist of viral structural proteins that, when overexpressed, spontaneously self-assemble into particles that are antigenically indistinguishable from infectious virus or subviral particles. VLPs can be considered as dense, repetitive arrays of one or more protein subunits with properties that are highly advantageous for use as stand-alone vaccines or as vaccine platforms. This review discusses the development of VLP-based platform technologies for vaccines against pathogens, as well as nontraditional targets such as self-antigens involved in chronic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available